Onwu Daniel Ocha | Drug Discovery | Best Researcher Award

Best Researcher Award

Onwu, Daniel Ocha
Affiliation University of Cross River State
Country Nigeria
Google Scholar ID n6jcvPsAAAAJ
Documents 9
Citations 2
h-index 1
Subject Area Drug Discovery
Event International Top Pharmaceutical Awards

Onwu Daniel Ocha – University of Cross River State

Onwu Daniel Ocha is a researcher affiliated with the University of Cross River State (UNICROSS), Calabar, Nigeria. His reported scholarly work is associated with computational biology, bioinformatics, drug discovery, network pharmacology, phytochemical investigation, and computational modelling. The supplied Google Scholar record reports nine documents, two citations, and an h-index of one. The profile also identifies computational biology and bioinformatics among the research areas associated with his scholarly activity.

Abstract

Onwu Daniel Ocha’s research profile reflects interdisciplinary activity connecting computational biology and bioinformatics with pharmaceutical and biomedical investigation. His available publication record includes research on phytochemicals, network pharmacology, computational modelling, biological targets, infectious diseases, and therapeutic investigation. These subjects are relevant to modern drug discovery because computational approaches can support the identification of candidate compounds, molecular targets, pathways, and potential mechanisms of action. His research record therefore demonstrates an emerging connection between computational science and pharmaceutical research. [1]

Keywords

Drug Discovery; Computational Biology; Bioinformatics; Network Pharmacology; Computational Modelling; Molecular Docking; Phytochemicals; Drug Target Identification; Systems Biology; Therapeutic Targeting; Pharmaceutical Research; In-silico Research; Biomedical Informatics.

Introduction

Computational biology and bioinformatics have become important components of modern pharmaceutical research. Computational approaches can be used to examine molecular interactions, biological pathways, disease-associated targets, and candidate therapeutic compounds before or alongside laboratory validation. Network pharmacology is particularly useful for studying complex relationships between compounds, proteins, pathways, and disease mechanisms. These approaches can contribute to the prioritization of potential therapeutic candidates and provide hypotheses for subsequent experimental research [1].

Research Profile

The supplied academic profile identifies Onwu Daniel Ocha with the University of Cross River State (UNICROSS), Calabar, Nigeria. His Google Scholar record reports nine documents, two citations, and an h-index of one. The research areas represented in the supplied profile include computational biology and bioinformatics, while the award profile specifically identifies Drug Discovery as the subject area. This combination places his research at the intersection of computational science and pharmaceutical investigation.[3]

Research Contributions

A notable contribution in the supplied publication record is the study titled In-Silico and Network Pharmacology Analysis of Mimosa invisa Phytochemicals against Testicular Inflammation. The work examines phytochemical compounds using computational approaches to investigate their potential relationships with inflammation-associated biological targets. This research direction is relevant to drug discovery because phytochemicals may provide candidate structures for further pharmacological investigation [3].

Publications

The available publication record demonstrates continuing scholarly activity in computational and biomedical research. Listed publications include studies on Mimosa invisa phytochemicals, biosynthesized silver nanoparticles, Terminalia catappa extracts, Allium cepa bioactive compounds, drug-resistant tuberculosis, Tefairia occidentalis phytocompounds, and computational analysis of antiviral targets. The diversity of these topics indicates an interdisciplinary research approach involving computational methods and biological investigation.[3].

Research Impact

The supplied Google Scholar profile reports two citations and an h-index of one. These bibliometric indicators represent the citation activity recorded by the profile at the time of the supplied document and may change as additional publications are indexed and cited. Therefore, citation indicators should be considered together with publication quality, research relevance, collaboration, and scientific contribution when assessing an emerging researcher.[4].

Award Suitability

The award assessment should nevertheless remain evidence-based and should consider the complete research portfolio, verified publication records, originality, methodological quality, scholarly contribution, collaboration, and the official eligibility criteria established by the award organizers. The available profile demonstrates an emerging publication record rather than providing sufficient evidence for unsupported claims of exceptional impact. This distinction maintains a neutral academic approach to recognition[4].

Conclusion

Onwu Daniel Ocha’s documented research profile demonstrates interdisciplinary activity involving computational biology, bioinformatics, drug discovery, network pharmacology, phytochemicals, and systems biology. The supplied record identifies nine documents, two citations, and an h-index of one, while the listed publications demonstrate research activity across several biomedical and pharmaceutical themes. [1].

References

  1. Onwu, D. O., Uraku, O. H., Agbi, M. T., & Uraku, A. J. (2026). In-silico and network pharmacology analysis of Mimosa invisa phytochemicals against testicular inflammation. In Silico Research in Biomedicine, 2, 100274.
    https://doi.org/10.1016/j.insi.2026.100274
  2. Onwu, D., Edun, S., Asuquo, U., & Bajepade, T. I. (2025). Antidiabetic potential of biosynthesized silver nanoparticles with fresh guava leaf. Covenant Journal of Physical and Life Sciences, 13(2), 1–6.
    https://journals.covenantuniversity.edu.ng/index.php/cjpls/article/view/4978
  3. Onwu, D. O., Kayode, D., Oluwatosin, C. E., Chimaobi, N. G., Johnson, O., et al. (2026). Assessing the effects of aqueous extract of Terminalia catappa on immunoglobulins levels in cyclophosphamide induced immunosuppressant Wistar rats. Next Research, 101441.
    https://doi.org/10.1016/j.nexres.2026.101441
  4. Onwu, D. O., Singh, A., Bajpai, Y., Akinlamilo, A. S., Habiganuchi, A., & Ibikunle, F. O. (2025). Host–pathogen interaction mapping in drug-resistant tuberculosis: A systems biology framework for dual therapeutic targeting. Research Square.
    https://doi.org/10.21203/rs.3.rs-7855974/v1
  5. Ahmad, A., Nnenna, A. O., Mamman, S., Nwokoro, C., Bello, A. M., Nseabasi, M. A., Abdulwakiil, M., Okpe, J., Onwu, D. O., Agbi, M., & Idoko, A. (2025). In-silico network pharmacology and computational modelling of bioactive compounds from Allium cepa targeting downstream protein effectors in diabetes. Research Square.
    https://doi.org/10.21203/rs.3.rs-8181479/v1

Basharat Ali | Drug Discovery and Development | Best Researcher Award

Assist. Prof. Dr. Basharat Ali | Drug Discovery and Development | Pakistan

University of Baltistan | Pakistan

Assist. Prof. Dr. Basharat Ali is a distinguished researcher and academician specializing in medicinal chemistry, heterocyclic synthesis, and polymer science with extensive expertise in designing and synthesizing biologically active compounds. Currently serving as an Assistant Professor in the Department of Chemistry at the University of Baltistan, Skardu, Pakistan, he has a diverse academic and research background, including postdoctoral research at the College of Pharmaceutical Science, Soochow University, China, where he contributed to the development of chemiluminescent dioxetane probes for disease diagnosis, fluorescent probes for hydrogen sulfide detection, and anthraquinone derivatives as anti-infective agents. He has also worked as a research assistant at Zhejiang University, China, focusing on mechanistic studies of olefin polymerization using Ξ±-Diimine nickel(II) catalysts, and at the HEJ Research Institute of Chemistry, University of Karachi, where he specialized in synthetic organic chemistry and bioactive heterocycles.Dr. Basharat Ali’s research interests include the synthesis, structural modification, and biological evaluation of medicinally important synthetic derivatives, probe design for environmental and biomedical applications, multicomponent reactions, polymer synthesis, and catalytic system development. He has supervised numerous postgraduate students and contributed extensively to the field with multiple high-impact publications in reputable international journals. Some of his significant research publications include Synthesis and biological evaluations of 1,3,4-thiadiazole derivatives as dual acting enzyme inhibitors to target inflammation and diabetes, Carbothioamides as anticancer agents: synthesis, in-vitro activity, structure-activity relationship evaluations and molecular docking, Synthesis of (E)-3-(aryl)-1-phenylprop-2-en-1-one Chalcone Derivatives for Hyperglycemic Effect in Diabetes.

Profile: Google Scholar

Featured Publications

Li, S., Zhan, L., Zhao, W., Zhang, S., Ali, B., Fu, Z., Lau, T. K., Lu, X., Shi, M., Li, C. Z., … (2018). Revealing the effects of molecular packing on the performances of polymer solar cells based on A–D–C–D–A type non-fullerene acceptors. Journal of Materials Chemistry A, 6(25), 12132–12141.

Ali, F., Khan, K. M., Salar, U., Iqbal, S., Taha, M., Ismail, N. H., Perveen, S., … (2016). Dihydropyrimidones: As novel class of Ξ²-glucuronidase inhibitors. Bioorganic & Medicinal Chemistry, 24(16), 3624–3635.

Abbas, A., Ali, B., Khan, K. M., Iqbal, J., Rahman, S. U., Zaib, S., Perveen, S. (2019). Synthesis and in vitro urease inhibitory activity of benzohydrazide derivatives, in silico and kinetic studies. Bioorganic Chemistry, 82, 163–177.

Ali, B., Khan, K. M., Hussain, S., Hussain, S., Ashraf, M., Riaz, M., Wadood, A., … (2018). Synthetic nicotinic/isonicotinic thiosemicarbazides: In vitro urease inhibitory activities and molecular docking studies. Bioorganic Chemistry, 79, 34–45.

Naz, F., Latif, M., Salar, U., Khan, K. M., Al-Rashida, M., Ali, I., Ali, B., Taha, M., … (2020). 4-Oxycoumarinyl linked acetohydrazide Schiff bases as potent urease inhibitors. Bioorganic Chemistry, 105, 104365.

Salar, U., Khan, K. M., Taha, M., Ismail, N. H., Ali, B., Perveen, S., Ghufran, M., … (2017). Biology-oriented drug synthesis (BIODS): In vitro Ξ²-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl aryl carboxylate derivatives. European Journal of Medicinal Chemistry, 125, 1289–1299.

Ali, M., Khan, K. M., Salar, U., Ashraf, M., Taha, M., Wadood, A., Hamid, S., Riaz, M., … (2018). Synthesis, in vitro Ξ±-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives. Molecular Diversity, 22(4), 841–861.

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED πŸŽ“, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc πŸ…, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). πŸŽ“πŸ“šπŸ‘¨β€πŸŽ“

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. πŸ₯πŸ“šπŸ‘¨β€πŸ«

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. πŸ“šπŸ”¬πŸ§‘β€πŸ«

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. πŸ’ΌπŸ“š

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. πŸ†πŸ“šπŸ”¬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. πŸ§‘β€βš•οΈπŸ½οΈπŸ’Š

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats